Abstract
Background Long COVID is a multisystem condition first identified in the COVID-19 pandemic characterised by a wide range of symptoms including fatigue, breathlessness and cognitive impairment. Considerable disagreement exists in who is most at risk of developing Long COVID, driven in part by incomplete coding of a Long COVID diagnosis in medical records.
Methods This was a retrospective observational cohort study using an integrated primary and secondary care dataset from North West London, covering over 2.7 million patients. Patients with Long COVID were identified through clinical terms in their primary care record. Multivariate logistic regression was used to identify factors associated with having Long COVID diagnosis, while multivariate quantile regression was used to identify factors predicting the time a Long COVID diagnosis was recorded.
Findings A total of 6078 patients were identified with a Long COVID clinical term in their primary care record, 0.33% of the total registered adult population. Women, those aged 41 to 70 years or of Asian ethnicity were more likely to have a recorded Long COVID diagnosis, alongside those with pre-existing anxiety, asthma, depressive disorder or eczema and those living outside of the most socioeconomically deprived areas. Men, those aged 41 to 70 years, or of black ethnicity were diagnosed earlier in the pandemic, while those with depressive disorder were diagnosed later.
Interpretation Long COVID is poorly coded in primary care records, and significant differences exist between patient groups in the likelihood of receiving a Long COVID diagnosis. Long COVID is more likely in those with pre-existing long-term conditions and is also associated with the frequent incidence of new long-term conditions. The experience of patients with Long COVID provides a crucial insight into inequities in access to timely care for complex multisystem conditions, and the importance of effective health informatics practices to provide robust, timely analytical support for front-line clinical services.
Funding National Institute for Health and Care Research (NIHR) Ref: COV-LT2-0016
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the National Institute for Health and Care Research. This work is supported by grants from the National Institute for Health and Care Research (NIHR - Ref: COV-LT2-0016) and NHS England. JC Acknowledges funding from the Wellcome Trust (215938/Z/19/Z). The views expressed in this publication are those of the authors and not necessarily those of NIHR, The Department of Health and Social Care, or NHS England.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for this study was granted by the Yorkshire & The Humber - Bradford Leeds Research Ethics Committee (reference: 21/YH/0276) and from the Health Research Authority Confidentiality Advisory Group under reference (reference: 303623).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
